Insurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.
All data from NYU Health Sciences Library Faculty Bibliography — -
Final results of phase II trial of doxorubicin HCl liposome injection followed by bexarotene in advanced cutaneous T-cell lymphoma
Straus, D J; Duvic, M; Horwitz, S M; Hymes, K; Goy, A; Hernandez-Ilizaliturri, F J; Feldman, T; Wegner, B; Myskowski, P L
2014 Jan;25(1):206-210, Annals of oncology
— id: 855292, year: 2014, vol: 25, page: 206, stat: Journal Article,
Rituximab, cyclophosphamide-fractionated, vincristine, doxorubicin and dexamethasone alternating with rituximab, methotrexate and cytarabine overcomes risk features associated with inferior outcomes in treatment of newly diagnosed, high-risk diffuse large B-cell lymphoma
Mato, Anthony; Feldman, Tatyana; Zielonka, Tania; Singavi, Arun; Gadaletta, Gabriella; Wa